Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1023) 1023
Book Review (248) 248
Publication (98) 98
Book Chapter (18) 18
Conference Proceeding (5) 5
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (833) 833
humans (794) 794
clinical neurology (489) 489
oncology (489) 489
male (462) 462
female (443) 443
adult (425) 425
middle aged (396) 396
gliomas (334) 334
anaplastic oligodendroglioma (329) 329
brain neoplasms - pathology (311) 311
chemotherapy (300) 300
brain neoplasms - genetics (297) 297
oligodendroglioma (278) 278
aged (275) 275
prognosis (275) 275
medicine & public health (231) 231
tumors (221) 221
glioblastoma (220) 220
survival (220) 220
glioma (216) 216
anaplastic astrocytoma (212) 212
radiotherapy (206) 206
anaplastic oligodendrogliomas (205) 205
temozolomide (197) 197
brain neoplasms - drug therapy (183) 183
pathology (183) 183
oligodendroglioma - genetics (179) 179
neurosciences (178) 178
surgery (176) 176
cancer (170) 170
phase-iii trial (170) 170
glioblastoma-multiforme (167) 167
adolescent (157) 157
radiation-therapy (156) 156
brain neoplasms - therapy (153) 153
brain neoplasms - mortality (150) 150
oligodendroglioma - pathology (149) 149
brain neoplasms - diagnosis (145) 145
neurology (136) 136
glioma - pathology (130) 130
astrocytoma (129) 129
treatment outcome (128) 128
chromosomes, human, pair 1 - genetics (123) 123
brain-tumors (122) 122
glioma - genetics (119) 119
retrospective studies (119) 119
young adult (116) 116
brain tumors (115) 115
magnetic resonance imaging (115) 115
survival analysis (111) 111
glioma - drug therapy (105) 105
malignant glioma (105) 105
mutation (105) 105
dacarbazine - analogs & derivatives (102) 102
19q (100) 100
chromosome deletion (99) 99
combined modality therapy (99) 99
care and treatment (97) 97
astrocytoma - pathology (96) 96
child (93) 93
diagnosis (93) 93
chromosomes, human, pair 19 - genetics (92) 92
analysis (91) 91
antineoplastic combined chemotherapy protocols - therapeutic use (90) 90
phase-ii trial (88) 88
oligodendroglioma - drug therapy (86) 86
central-nervous-system (84) 84
brain neoplasms - surgery (82) 82
immunohistochemistry (82) 82
disease-free survival (81) 81
survival rate (81) 81
isocitrate dehydrogenase - genetics (79) 79
anaplastic glioma (76) 76
oligodendroglioma - diagnosis (76) 76
brain cancer (75) 75
malignant gliomas (74) 74
comparative genomic hybridization (73) 73
neurosurgery (73) 73
classification (72) 72
antineoplastic agents - therapeutic use (71) 71
astrocytoma - genetics (71) 71
procarbazine (71) 71
brain neoplasms - radiotherapy (70) 70
glioma - diagnosis (70) 70
follow-up studies (69) 69
prognostic-factors (69) 69
research (69) 69
dacarbazine - therapeutic use (68) 68
oligodendroglioma - mortality (68) 68
glioma - therapy (67) 67
brain neoplasms - metabolism (66) 66
aged, 80 and over (64) 64
european organization (63) 63
oligodendroglioma - therapy (63) 63
glioma - mortality (62) 62
oligodendroglial tumors (62) 62
lomustine (61) 61
abridged index medicus (60) 60
disease progression (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (984) 984
French (19) 19
German (13) 13
Japanese (9) 9
Czech (6) 6
Spanish (4) 4
Korean (3) 3
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Oligodendroglia
by Norton, William T
1984, ISBN 030641547X, Volume 5, xviii, 351
Neurochemistry | Oligodendroglia
Book
Details down arrow
2. Full Text Anaplastic Oligodendroglioma with Transdural Extension
by Tan, Ai Peng and Tan, Char Loo and Pang, Yin Huei and Kei, Pin Lin
World Neurosurgery, ISSN 1878-8750, 10/2019, Volume 130, pp. 10 - 12
Oligodendrogliomas, the third most common primary gliomas, have a strict molecular definition, characterized by the combined presence of isocitrate... 
Transdural extension | Anaplastic oligodendroglioma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Scalp Metastasis of Anaplastic Oligodendroglioma
by Wu, Liang and Ou, Yunwei and Liu, Baiyun and Liu, Weiming
World Neurosurgery, ISSN 1878-8750, 08/2019, Volume 128, pp. 448 - 451
Scalp metastases from anaplastic oligodendroglioma (AO) are extremely rare and mostly involve intracranial recurrence or widely metastatic disease. Here we... 
Surgical resection | Radiotherapy | Surgical seeding | Scalp metastasis | Anaplastic oligodendroglioma | SURGERY | SURGICAL PATHWAY | CLINICAL NEUROLOGY | Medicine, Experimental | Medical research | Relapse | Metastasis | World health | Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Case 38-2016
: A 52-Year-Old Woman with Recurrent Oligodendroglioma
by Chi, Andrew S and Cahill, Daniel P and Larvie, Mykol and Louis, David N
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 24, pp. 2381 - 2389
A 52-year-old woman who had had low-grade oligodendroglioma 12 years earlier was seen for routine follow-up. Imaging studies revealed progression of the... 
ASTROCYTOMA | MEDICINE, GENERAL & INTERNAL | ANAPLASTIC OLIGODENDROGLIOMA | LOW-GRADE GLIOMA | TERM-FOLLOW-UP | RANDOMIZED-TRIAL | CLASSIFICATION | RADIOTHERAPY | MUTATIONS | VINCRISTINE CHEMOTHERAPY | PROCARBAZINE | Diagnosis, Differential | Oligodendroglioma - surgery | Dacarbazine - therapeutic use | Humans | Middle Aged | Brain Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Ki-67 Antigen - metabolism | Brain Neoplasms - drug therapy | Neoplasm Recurrence, Local - surgery | Brain Neoplasms - surgery | Antineoplastic Agents, Alkylating - therapeutic use | Neoplasm Recurrence, Local - pathology | Magnetic Resonance Imaging | Frontal Lobe - surgery | Oligodendroglioma - pathology | Biopsy | Dacarbazine - analogs & derivatives | Female | Chemotherapy, Adjuvant | Mutation | Frontal Lobe - pathology | Oligodendroglioma - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
by Sahm, Felix and Reuss, David and Koelsche, Christian and Capper, David and Schittenhelm, Jens and Heim, Stephanie and Jones, David T. W and Pfister, Stefan M and Herold-Mende, Christel and Wick, Wolfgang and Mueller, Wolf and Hartmann, Christian and Paulus, Werner and von Deimling, Andreas
Acta Neuropathologica, ISSN 0001-6322, 10/2014, Volume 128, Issue 4, pp. 551 - 559
Astrocytoma and oligodendroglioma are histologically and genetically well-defined entities. The majority of astrocytomas harbor concurrent TP53 and ATRX... 
Pathology | Neurosciences | Medicine & Public Health | 1p/19q | IDH1 | ATRX | Mixed glioma | Oligoastrocytoma | TP53 | IDH2 MUTATIONS | PROTEIN | 19Q | HYBRIDIZATION | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | BRAIN-TUMORS | FREQUENT ATRX | THERAPY | P53 GENE | ANAPLASTIC GLIOMAS | Astrocytoma - genetics | Chromosome Deletion | Molecular Biology | Oligodendroglioma - genetics | Humans | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Male | X-linked Nuclear Protein | Mutation - genetics | Tumor Suppressor Protein p53 - genetics | Chromosomes, Human, Pair 19 | Chromosomes, Human, Pair 1 | Brain Neoplasms - classification | Female | Retrospective Studies | Astrocytoma - classification | Oligodendroglioma - classification | Nuclear Proteins - genetics | DNA Helicases - genetics | Immunohistochemistry | Molecular genetics | Tumor proteins | Gliomas | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text P08.51 Extracranial metastasis of oligodendroglioma
by Sequeira, M and Rosinha, A
Neuro-Oncology, ISSN 1522-8517, 10/2016, Volume 18, Issue suppl_4, pp. iv53 - iv53
P08 Glioblastom and Anaplastic gliomas
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinicopathologic Features of Pediatric Oligodendrogliomas: A Series of 50 Patients
by Rodriguez, Fausto J and Tihan, Tarik and Lin, Doris and McDonald, William and Nigro, Janice and Feuerstein, Burt and Jackson, Sadhana and Cohen, Kenneth and Burger, Peter C
The American Journal of Surgical Pathology, ISSN 0147-5185, 08/2014, Volume 38, Issue 8, pp. 1058 - 1070
Oligodendrogliomas are an important adult form of diffuse gliomas with a distinctive clinical and genetic profile. Histologically similar tumors occurring... 
brain tumor | pediatric glioma | 1p19q | IDH1 | Oligodendroglioma | SURGERY | oligodendroglioma | DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR | 19Q LOSS | IDH1 MUTATIONS | PATHOLOGY | LOW-GRADE GLIOMAS | FREQUENT ATRX | CHILDREN | ANAPLASTIC OLIGODENDROGLIOMA | MALIGNANT GLIOMAS | MICROSATELLITE-ANALYSIS | OF-THE-LITERATURE | Chromosome Deletion | Immunohistochemistry | Oligodendroglioma - mortality | Oligodendroglioma - genetics | Humans | Brain Neoplasms - pathology | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Child, Preschool | In Situ Hybridization, Fluorescence | Infant | Male | Young Adult | Chromosomes, Human, Pair 1 | Oligodendroglioma - pathology | Adolescent | Polymerase Chain Reaction | Female | Brain Neoplasms - mortality | Child | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
by Yip, Stephen and Butterfield, Yaron S and Morozova, Olena and Chittaranjan, Suganthi and Blough, Michael D and An, Jianghong and Birol, Inanc and Chesnelong, Charles and Chiu, Readman and Chuah, Eric and Corbett, Richard and Docking, Rod and Firme, Marlo and Hirst, Martin and Jackman, Shaun and Karsan, Aly and Li, Haiyan and Louis, David N and Maslova, Alexandra and Moore, Richard and Moradian, Annie and Mungall, Karen L and Perizzolo, Marco and Qian, Jenny and Roldan, Gloria and Smith, Eric E and Tamura‐Wells, Jessica and Thiessen, Nina and Varhol, Richard and Weiss, Samuel and Wu, Wei and Young, Sean and Zhao, Yongjun and Mungall, Andrew J and Jones, Steven JM and Morin, Gregg B and Chan, Jennifer A and Cairncross, J Gregory and Marra, Marco A
The Journal of Pathology, ISSN 0022-3417, 01/2012, Volume 226, Issue 1, pp. 7 - 16
Oligodendroglioma is characterized by unique clinical, pathological, and genetic features. Recurrent losses of chromosomes 1p and 19q are strongly associated... 
glioma | oligodendroglioma | Capicua | IDH1 | next‐generation sequencing | next-generation sequencing | GLIOMAS | SURVIVAL | ANAPLASTIC OLIGODENDROGLIOMAS | PATHOLOGY | ATAXIN-1 | BRAIN-TUMORS | ALIGNMENT | ONCOLOGY | SIGNALING PATHWAY | MSH6 MUTATIONS | CELL | Oligodendroglioma - mortality | Oligodendroglioma - genetics | Biomarkers, Tumor - analysis | Humans | Brain Neoplasms - pathology | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Repressor Proteins - genetics | Isocitrate Dehydrogenase - genetics | Chromosomes, Human, Pair 19 - genetics | Disease-Free Survival | Neoplasm Grading | Oligodendroglioma - pathology | Biomarkers, Tumor - genetics | Brain Neoplasms - mortality | Mutation | Chromosomes, Human, Pair 1 - genetics | Index Medicus | Glioma | Next Generation Sequencing | Oligodendroglioma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
by Buckner, Jan C and Shaw, Edward G and Pugh, Stephanie L and Chakravarti, Arnab and Gilbert, Mark R and Barger, Geoffrey R and Coons, Stephen and Ricci, Peter and Bullard, Dennis and Brown, Paul D and Stelzer, Keith and Brachman, David and Suh, John H and Schultz, Christopher J and Bahary, Jean-Paul and Fisher, Barbara J and Kim, Harold and Murtha, Albert D and Bell, Erica H and Won, Minhee and Mehta, Minesh P and Curran, Walter J
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1344 - 1355
Patients with grade 2 glioma were randomly assigned to radiation therapy alone or radiation therapy plus six cycles of chemotherapy. The median overall... 
MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOMA | THERAPY | ANAPLASTIC OLIGODENDROGLIOMA | LOMUSTINE | TERM-FOLLOW-UP | RADIOTHERAPY | CANCER | CHEMOTHERAPY | Procarbazine - administration & dosage | Astrocytoma - radiotherapy | Oligodendroglioma - mortality | Follow-Up Studies | Humans | Male | Combined Modality Therapy | Brain Neoplasms - drug therapy | Oligodendroglioma - radiotherapy | Young Adult | Disease-Free Survival | Neoplasm Grading | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Astrocytoma - drug therapy | Survival Analysis | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Lomustine - administration & dosage | Astrocytoma - mortality | Oligodendroglioma - drug therapy | Procarbazine | Care and treatment | Chemotherapy | Usage | Gliomas | Lomustine | Dosage and administration | Cancer | Brain cancer | Radiation therapy | Oligoastrocytoma | Survival | Patients | Vincristine | Oligodendroglioma | Glioma | Biopsy | Astrocytoma | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma
by Chamberlain, Marc C and Johnston, Sandra
Cancer, ISSN 0008-543X, 04/2009, Volume 115, Issue 8, pp. 1734 - 1743
BACKGROUND: A retrospective evaluation of single agent bevacizumab was carried out in adults with recurrent alkylator-refractory 1p19q codeleted anaplastic... 
Recurrent anaplastic oligodendroglioma | Refractory | Chemotherapy | Alkylator | Bevacizumab | ADJUVANT CHEMOTHERAPY | refractory | GLIOBLASTOMA-MULTIFORME | PROGRESSIVE MALIGNANT GLIOMA | alkylator | 13-CIS-RETINOIC ACID | recurrent anaplastic oligodendroglioma | chemotherapy | RADIATION-THERAPY | PHASE-III TRIAL | SALVAGE CHEMOTHERAPY | VENOUS THROMBOEMBOLISM | ONCOLOGY | BRAIN-TUMOR CONSORTIUM | bevacizumab | HIGH-GRADE GLIOMAS | Oligodendroglioma - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal, Humanized | Disease-Free Survival | Chromosomes, Human, Pair 1 | Astrocytoma - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Retrospective Studies | Oligodendroglioma - drug therapy | Gliomas | Care and treatment | Research | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH
by Cairncross, J. Gregory and Cairncross, J Gregory and Wang, Meihua and Wang, Meihua and Jenkins, Robert B and Jenkins, Robert B and Shaw, Edward G and Shaw, Edward G and Giannini, Caterina and Giannini, Caterina and Brachman, David G and Brachman, David G and Buckner, Jan C and Buckner, Jan C and Fink, Karen L and Fink, Karen L and Souhami, Luis and Souhami, Luis and Laperriere, Normand J and Laperriere, Normand J and Huse, Jason T and Huse, Jason T and Mehta, Minesh P and Mehta, Minesh P and Curran Jr, Walter J and Curran Jr, Walter J
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 8, pp. 783 - 790
Purpose Patients with 1p/19q codeleted anaplastic oligodendroglial tumors who participated in RTOG (Radiation Therapy Oncology Group) 9402 lived much longer... 
PHASE-III TRIAL | BREAST-CANCER | ADJUVANT PROCARBAZINE | SUCCESSFUL CHEMOTHERAPY | PROGNOSTIC-FACTORS | ONCOLOGY | ANAPLASTIC OLIGODENDROGLIOMA | MGMT GENE | EUROPEAN-ORGANIZATION | GROUP TRIAL 9402 | BRAIN-TUMORS | Procarbazine - administration & dosage | Multivariate Analysis | Oligodendroglioma - genetics | Humans | Middle Aged | Brain Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Chemoradiotherapy | Patient Selection | Time Factors | Vincristine - administration & dosage | Female | Brain Neoplasms - mortality | Odds Ratio | Precision Medicine | Oligodendroglioma - mortality | Brain Neoplasms - enzymology | Gene Frequency | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Treatment Outcome | Oligodendroglioma - enzymology | Chi-Square Distribution | Disease Progression | Polymorphism, Genetic | Disease-Free Survival | Oligodendroglioma - therapy | Oligodendroglioma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Brain Neoplasms - therapy | Isocitrate Dehydrogenase - metabolism | Mutation | Lomustine - administration & dosage | Index Medicus | To2 | Neur1 | Neur6 | Original Reports | Neur7 | To22 | Neur8
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Survey of treatment recommendations for anaplastic oligodendroglioma
by Abrey, Lauren E and Louis, David N and Paleologos, Nina and Lassman, Andrew B and Raizer, Jeffrey J and Mason, Warren and Finlay, Jonathan and MacDonald, David R and DeAngelis, Lisa M and Cairncross, J. Gregory and Oligodendroglioma Study Grp and Oligodendroglioma Study Group
Neuro-Oncology, ISSN 1522-8517, 07/2007, Volume 9, Issue 3, pp. 314 - 318
Anaplastic oligodendroglioma is a malignant brain tumor uniquely sensitive to treatment with both chemotherapy and radiotherapy. There are few prospective... 
Molecular genetic studies | Treatment recommendations | Survey | 19q | Temozolomide | Radiotherapy | Anaplastic oligodendroglioma | temozolomide | SURVIVAL | DIAGNOSIS | PHASE-II | molecular genetic studies | anaplastic oligodendroglioma | TUMORS | treatment recommendations | CHEMOTHERAPY | CLINICAL NEUROLOGY | GLIOBLASTOMA | ONCOLOGY | PREDICTORS | radiotherapy | survey | Oligodendroglioma - genetics | Brain Neoplasms - diagnosis | Humans | Oligodendroglioma - diagnosis | Brain Neoplasms - genetics | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Data Collection | Practice Patterns, Physicians | Molecular Biology - trends | Oligodendroglioma - therapy | Brain Neoplasms - therapy | Index Medicus | Clinical Investigations | 1p
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Tumor cell-specific chromosomal abnormality in the vascular endothelial cells of anaplastic oligodendroglioma
by Jiang, Haihui and Zhang, Zhe and Ren, Xiaohui and Zeng, Wei and Wang, Junmei and Lin, Song
Journal of Neurosurgery, ISSN 0022-3085, 10/2016, Volume 125, Issue 4, pp. 995 - 1001
OBJECTIVE 1p/19q co-deletion is a well-established tumor cell specific chromosomal abnormality in oligodendroglial tumors. The endothelial cells (ECs) of... 
Angiogenesis | Oncology | Prognosis | 1p/19q | Anaplastic oligodendroglioma | Endothelial cells | SURGERY | endothelial cells | BEVACIZUMAB | angiogenesis | PATHOLOGY | anaplastic oligodendroglioma | prognosis | oncology | CLINICAL NEUROLOGY | TEMOZOLOMIDE | TRIAL | GLIOBLASTOMA | RADIOTHERAPY | Chromosome Deletion | Endothelial Cells | Oligodendroglioma - genetics | Humans | Middle Aged | Brain Neoplasms - genetics | Male | Young Adult | Chromosome Aberrations | Adult | Female | Chromosomes, Human, Pair 1 - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Anaplastic Oligodendroglioma: A New Treatment Paradigm and Current Controversies
by Roth, Patrick and Wick, Wolfgang and Weller, Michael
Current Treatment Options in Oncology, ISSN 1527-2729, 12/2013, Volume 14, Issue 4, pp. 505 - 513
Anaplastic oligodendroglial tumors have gained increasing interest with the emerging role of molecular markers and systemic chemotherapy during the past years.... 
Chemotherapy | Medicine & Public Health | Irradiation | Oncology | Procarbazine, lomustine and vincristin | Temozolomide | Anaplastic oligodendroglioma | BEVACIZUMAB | GLIOMA | LOMUSTINE | VINCRISTINE CHEMOTHERAPY | PHASE-III TRIAL | BRAIN-TUMOR | ADJUVANT PROCARBAZINE | ONCOLOGY | RECURRENT | RADIOTHERAPY | Procarbazine - administration & dosage | Oligodendroglioma - mortality | Oligodendroglioma - genetics | Humans | Lomustine - adverse effects | Radiotherapy, High-Energy | Brain Neoplasms - genetics | Male | Combined Modality Therapy | Patient Selection | Oligodendroglioma - therapy | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Deletion | Brain Neoplasms - therapy | Survival Analysis | Quality of Life | Vincristine - administration & dosage | Vincristine - adverse effects | Female | Brain Neoplasms - mortality | Lomustine - administration & dosage | Care and treatment | Usage | Reports | Forecasts and trends | Radiotherapy | Oligodendroglioma | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma
by Wagner, Matthias W and Poretti, Andrea and Huisman, Thierry A. G. M and Bosemani, Thangamadhan
Child's Nervous System, ISSN 0256-7040, 6/2015, Volume 31, Issue 6, pp. 885 - 891
Oligodendroglioma are rare pediatric brain tumors. The literature about neuroimaging findings is scant. A correct presurgical diagnosis is important to plan... 
Neuroimaging | Neurosciences | Medicine & Public Health | Susceptibility weighted imaging | Neurosurgery | Children | Oligodendroglioma | Diffusion tensor imaging | GLIOMAS | SURGERY | ASTROCYTOMAS | 19Q | CLINICAL NEUROLOGY | BRAIN-TUMORS | ANAPLASTIC OLIGODENDROGLIOMA | PEDIATRICS | CENTRAL-NERVOUS-SYSTEM | DIFFERENTIATION | LOW-GRADE OLIGODENDROGLIOMAS | Brain Neoplasms - diagnosis | Humans | Oligodendroglioma - diagnosis | Child, Preschool | Male | Diffusion Tensor Imaging - methods | Young Adult | Image Processing, Computer-Assisted | Anisotropy | Adolescent | Female | Retrospective Studies | Diffusion Magnetic Resonance Imaging - methods | Child | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Oligodendrogliomas in children
by Creach, Kimberly M and Rubin, Joshua B and Leonard, Jeffery R and Limbrick, David D and Smyth, Matthew D and Dacey, Ralph and Rich, Keith M and Dowling, Joshua L and Grubb Jr, Robert L and Linette, Gerald P and King, Allison A and Michalski, Jeff M and Park, Tae Sung and Perry, Arie and Simpson, Joseph R and Mansur, David B
Journal of Neuro-Oncology, ISSN 0167-594X, 1/2012, Volume 106, Issue 2, pp. 377 - 382
Oligodendrogliomas are rare central nervous system (CNS) tumors in children. The purpose of this study was to identify prognostic factors for progression free... 
Neurology | Medicine & Public Health | Glioma | Adolescent | Oncology | Oligoastrocytoma | Pediatric | Prognostic factors | Oligodendroglioma | PRIMARY BRAIN-TUMORS | UNITED-STATES | SURVIVAL | ANAPLASTIC OLIGODENDROGLIOMAS | PROGNOSTIC-FACTORS | PEDIATRIC OLIGODENDROGLIOMAS | 19Q | TRENDS | MIXED GLIOMAS | CLINICAL NEUROLOGY | PHASE-III TRIAL | ONCOLOGY | Oligodendroglioma - mortality | Prognosis | Humans | Risk Factors | Brain Neoplasms - pathology | Kaplan-Meier Estimate | Child, Preschool | Infant | Male | Treatment Outcome | Disease Progression | Disease-Free Survival | Neurosurgical Procedures | Oligodendroglioma - therapy | Oligodendroglioma - pathology | Brain Neoplasms - therapy | Female | Retrospective Studies | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Child | Chemotherapy | Gliomas | Analysis | Children | Radiotherapy | Health aspects | Cancer | Index Medicus | Pediatrics | oligodendroglioma | Central nervous system | Radiation | Data processing | Multivariate analysis | Survival | Biopsy | Age | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights